Products for Research Use Only
RegisterLogin

Lirilumab

CAT: 1410-M36889-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M36889-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN) .
CAS Number
1000676-41-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Virus Protease

1000676-41-4

PubChem
cas1000676-41-4
nameLirilumab
PubChem SID481155331
sourceBOC Sciences
Source CategoryChemical Vendors
External ID1000676-41-4
valueLive
deposit2023-05-11
modify2025-07-05
available2023-05-11
descriptionPlease note that the substance record is presented as provided to PubChem by the source (depositor).
synonyms
Lirilumab1000676-41-4Anti-KIR (1-7F9)
PubChem LinkClick here

Alternative Products

CatalogName
MBS5819212Lirilumab
GTR18333604-01Lirilumab Antibody
048085KIR (lirilumab) discontinued
KPTX233Lirilumab ELISA Kit
KBI1435KRIBIOLISA™ Lirilumab ELISA
C00226-01Lirilumab (Anti-KIR)
HW759016-01Research Grade Lirilumab
591974Lirilumab (KIRD2 subgroup)
E55B0405Lirilumab (Reference antibody)

Popular Products